Diagnostic and prognostic value of carcinoembryonic antigen in pancrea | OTT
Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?
Should I take a Cancer Marker Test? | Positive Bioscience
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
CA 19-9 Antigen - an overview | ScienceDirect Topics
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - Journal of Clinical Laboratory Analysis - Wiley Online Library
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Tumor Markers in Pancreatic Cancer: 2013
Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
TUMOR MARKERS OF COLORECTAL CARCINOMA
![PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table1-1.png "PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar")
PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
Tumor Markers : All you need to know
Tumor Marker Screening For Men & Women At IDC
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA19-9 - Wikipedia
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
